The Best Thing About Neuromodulation Therapy
If you suffer from chronic pain, migraines, bladder dysfunction, or inflammatory bowel disease, neuromodulation therapy is an option. It is a non-invasive treatment that can improve your quality of life and decrease pain and inflammation.
Neuromodulation treatments are also a great alternative to opioids. They can reduce opioid side effects such as drowsiness, constipation, and mental cloudiness.
The Best Thing About Neuromodulation Therapy is That It Can Treat Almost Every Disease or Symptom
Neuromodulation therapy is a relatively new treatment proven to help decrease pain levels for those suffering from chronic pain. It also reduces the need for opioid medications and can significantly improve quality of life.
Unlike many traditional medications, neuromodulation therapy can target specific areas of the brain or nervous system to treat symptoms. This makes it an effective treatment option for patients who have not found relief with other therapies.
Another advantage of this treatment is that it can be tailored to each patient’s needs. For example, neuromodulation may be used to treat essential tremor, a disorder that causes a person’s arms to shake rhythmically when performing simple self-care tasks.
Neuromodulation can also be combined with neurofeedback, a treatment that uses mild electrical stimulation to teach the body how to generate healthier brain wave patterns for improved function and self-regulation. This combination can increase blood flow in the damaged area and reduce inflammation.
It Can Be Used to Treat Migraines
A migraine is a headache that can cause pain, nausea, and sensitivity to light and sound. Many things, including stress and certain foods or activities, can trigger them.
Medications can help reduce the number of migraines that you have. However, they can also have side effects like drowsiness or rebound headaches.
There are now several new non-drug approaches to treating migraines. These include digital therapeutic devices, which use electrical pulses to stimulate nerves in your upper arm.
Another non-drug treatment is external trigeminal nerve stimulation (ETNS), which uses a device called Cefaly to stimulate the part of the trigeminal nerve that runs around your eye.
Neuromodulation therapy can be used for acute and chronic headache disorders, including migraines and cluster headaches. In addition, this type of therapy is helpful for people who don’t respond well to medications or have a refractory migraine disorder.
It Can Be Used to Treat Bladder Dysfunction
If you’re experiencing symptoms of urinary incontinence (leaving you unable to empty your bladder), you may be able to benefit from neuromodulation therapy. This procedure can help to control the symptoms in those who have failed to respond to behavioral treatments or medications.
One treatment option involves a small, pacemaker-like device surgically implanted into the fleshy part of your buttocks. This device delivers low-voltage pulses that stimulate the sacral nerves that affect bladder function.
This method of treating urologic disorders is often successful in women who have not responded to traditional medical management, such as lifestyle changes, medication, or biofeedback.
A trial of this therapy is usually performed, which can be done over three days, to see if it helps improve the symptoms you are experiencing. If it does, you will need surgery to implant the neurotransmitter device permanently.
It Can Be Used to Treat Inflammatory Bowel Disease
There is evidence that neuromodulation therapy can treat inflammatory bowel disease (IBD). It can improve pain, reduce inflammation and relieve symptoms.
Patients with IBD can be treated with various medications and surgical procedures but often experience side effects and discomfort. Neuromodulation can be a safe, effective, and cost-effective alternative.
Preliminary research suggests that non-invasive vagal nerve stimulation (nVNS) inhibits inflammation in experimental animal models of inflammatory bowel disease and has anti-tumor necrosis factor alpha activity in human subjects with Crohn’s disease.
In an animal study, abdominal VNS reduced inflammation following TNBS-induced inflammation of the small intestine in rats. The treatment improved ECAPs, stool quality and blood in stools, and reduced CRP levels in the plasma, compared to the control group, which was injected with TNBS alone.